The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...
For the second time this year, the FDA has approved a nonprescription naloxone nasal spray to counteract the effects of opioid overdose. The latest regulatory decision is for a product from Harm ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback